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2-3) and Group 2 (SS above or equal to the median and CAC 2-3). After
discharge patients were followed in an outpatients basis, recording major
events and focusing in AAE. Survival-free of AAE curves were calculated
with the Kaplan-Maier method. In order to avoid the potential bias of
confusion variables, we used a multivariate proportional hazards Cox
model, including all variables with a p<0.2 at univariate analysis. Final
resultswerepresentedashazard ratio (HR) forAAEwith its 95%conﬁdence
interval (95% CI).
RESULTS Median follow up was 1.79 years (RIC 0.94-2.86). Median SS
was 14 (RIC 7-23).Clinical variables are listed in Table 1. During follow
up a total of 27 AAE were recorded. Group 0: 8 events (6.6%), Group 1:
9 events (8.5%), and Group 2: 10 events: (23.8%). The Kaplan-Maier
curves are shown in Figure 1. After multivariate Cox analysis, adjusted
HR were the following: HR 4.31 (CI95%: [1.69-11.03], p¼0.002) (com-
parison of group 2 vs. group 0); HR 3.28 (CI95%: [1.28-8.38], p¼0.013)
(group 2 vs. group 1) and HR 1.3 (CI95%: [0.49-3.52], p¼0.013)(group 1
vs. group 0).VariableTotal
population
(N[270)Group 0
(SS<14
and BC 0-1)
122 patientsGroup 1
(SS ‡14
or BC 2-3)
106 patientsGroup 2
(SS ‡14
and BC 2-3)
42 patients p valueAge (yrs) 65.0 (54.0-76.0) 62 (51-73) 66.5 (55-77) 76.5 (65-81) 0.001Men 66.7% 60.7% 76.4% 59.5% 0.44Body mass
index
(kg/m2)27.9 (25.5-30.9) 28.5 (25.8-31.7) 27.7 (25.1-30.2) 27.7 (24.6-
30.1)0.35Diabetes mellitus 20.7% 15.6% 22.6% 31% 0.028Smoker (present
or former)68.9% 70.5% 69.8% 61.9% 0.37Hypertension 70% 59% 79.1% 78.6% 0.002LV ejection
fraction60.0% (50.0-67.0) 60.0% (52.0-70.0) 57.0% (46.0-64) 60% (45-67) 0.017Aspirin 91.1% 95.9% 85.8% 90.5% 0.025Clopidogrel 74.8% 71.3% 79.2% 73.8% 0.38Acenocumarol 5.9% 7.9% 6.6% 7.1% 0.81Statins 93% 91.8% 92.5% 97.6% 0.35b-Blockers 70.7% 68.9% 71.7% 73.8% 0.80STEMI 46.7% 45.1% 56.6% 26.2% 0.03Complete
revascularization70% 81.1% 65.1% 50% 0.001CONCLUSIONS According to our data the combination of SS (14) and
high CAC (2-3) is a strong predictor of AAE, in patients admitted with
an ACS. Further studies are needed to test our results.CATEGORIES CORONARY: Angiography and QCA
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BACKGROUND Coronary artery bypass surgery (CABG) is recom-
mended by guidelines in several scenarios. However, the early oc-
clusion of the grafts is not uncommon. Some clinical factors have been
described as predictors of this early dysfunction but the impact of the
grafted distal vessel on outcomes is poorly understood. We aimed to
develop a new simple angiographic score that would predict patency
problems of the grafts in short- and mid-term.
METHODS We enrolled 249 consecutive patients. All of them under-
went CABG with a mean of 6-year follow-up. “Distal Vessel Quality”
(DVQ) score was calculated by assigning a value from 0 to 9 according
to the criteria of visibility, diameter and size of the distal vessel an-
giographically evaluated. Each variable was quantiﬁed from 0 (worst)
to 3 (best). The mean DVQ score was the result of the cumulative
scores for all distal vessels that were grafted divided by the number of
vessels. Two independent cardiologists, blind to the outcomes,
calculated the DVQ score with low interobserver variability.
RESULTS Mean age was 66.3  9.7 years, 82.7% were males and risk
factors included were: high blood pressure (53.4%), diabetes (30.5%)
and dyslipidemia (49.8%). Each patient received an average of 2.9
grafts until a total of 741, especially to the anterior descending artery
(33%) and obtuse marginal artery (OM) (27%). A total of 453 (61%)
venous grafts and 287 (39%) arterial grafts were implanted. At follow-
up 16% of the patients were admitted due to STEMI (0.4%), non-STEMI
(2%), unstable angina (8.4%) and stable angina (5.2%). Occlusion of 67
grafts was angiographically demonstrated at an average time from
surgery of 511 days (IQR, 168-606), particularly affecting those sutured
to the OM (37%). The occlusion was more often in men (13 vs 3%, p ¼
0.03), venous grafts (11.6 vs 7%, p ¼ 0.01) and patients with lower
single vessel score (5.78  1.01 vs. 6.47  1.36, p ¼ 0.006) and mean
DVQ score (5.86  1.03 vs. 6.32  0.79, p ¼ 0.019). Multivariate analysis
showed that the use of arterial grafts (OR ¼ 0.217, 95% CI [0064-0737],
p ¼ 0.014) and higher values of DVQ score (OR ¼ 0.555, 95% CI [0370-
0832], p ¼ 0.004) were related to longer patency of the grafts.
CONCLUSIONS The DVQ score is a new simple tool to predict out-
comes of coronary artery bypass grafts. Lower values of this score
suggest little beneﬁt of grafting certain vessels. Therefore, this score
could be useful to identify patients who may beneﬁt from percuta-
neous revascularization or hybrid strategies.
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BACKGROUND The difference in prognostic discrimination between
visual assessment of coronary stenosis and quantitative coronary
angiography (QCA) for obstructive disease in patients with suspected
coronary artery disease (CAD) is not known.
METHODS In the PROMISE trial, 10,003 patients with symptoms
suggestive of CAD were randomized to anatomical or functional
testing. Site reports detailing visual stenosis were collected for
